📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
210 analysed today
FollowTelegram
210
Today
152,072
All-time analysed
43,617
Positive
6,746
Negative
92,862
Neutral
8,779
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
848 announcements match the current filters (relevance ≥ 5).
Panacea Biotec Wins Major Tax Case; ₹329.49 Crore Tax Demand Cancelled by ITAT
Panacea Biotec has received a favorable ruling from the Income Tax Appellate Tribunal (ITAT) regarding long-standing tax disputes for Assessment Years 2005-06 to 2012-13. The ITAT dismissed eight appeals by the tax department and allowed two appeals by the company, effectively quashing the previous assessment orders. This decision results in the cancellation of a massive tax demand totaling ₹329.49 Crore. The ruling removes a significant contingent liability and potential penalty exposure from the company's financial records.
Key Highlights
ITAT quashed assessment orders for eight Assessment Years spanning 2005-06 to 2012-13.
Cancellation of a total tax demand amounting to ₹329.49 Crore previously raised by the Assessing Officer.
Deletion of all expense disallowances that were under litigation since Financial Year 2015-16.
The ruling dismisses eight appeals filed by the Deputy Commissioner of Income Tax (DCIT) against the company.
👀 What to Watch
This is a significant positive development that strengthens the balance sheet by removing a large liability; investors should monitor if the tax department files a further appeal in the High Court.
Hester Biosciences Re-appoints Rajiv Gandhi as CEO & MD for 3 Years with 99.54% Approval
Hester Biosciences has announced the successful re-appointment of Mr. Rajiv Gandhi as CEO and Managing Director for a three-year term effective from April 1, 2026. The special resolution was passed via a postal ballot process with an overwhelming 99.54% of valid votes cast in favor. While the promoter group showed 100% support, a significant majority of the small institutional voting block (99.24%) voted against the resolution. This move ensures leadership continuity for the company through March 2029.
Key Highlights
Special resolution for re-appointment of Rajiv Gandhi as CEO & MD passed with 99.54% majority.
The new term is effective for three years from April 1, 2026, to March 31, 2029.
Total valid votes cast represented 4,075,085 shares, with 4,056,419 votes in favor.
Promoter group cast 3,451,082 votes, showing 100% internal support for the leadership.
Public institutional holders showed 99.24% dissent, though this represented only 18,570 shares.
👀 What to Watch
Investors should take confidence in the leadership continuity which supports long-term strategic stability. No immediate action is required as the current management remains at the helm.
Tasty Bite Appoints Industry Veteran Tushar Srivastava as Senior Director of Food Service
Tasty Bite Eatables Limited has appointed Mr. Tushar Srivastava as the Senior Director for its Tasty Bite Food Service (TFS) division, effective March 09, 2026. Mr. Srivastava brings over 28 years of extensive experience from major FMCG and food companies including PepsiCo, Walmart, and Jubilant FoodWorks. His expertise spans across General Trade, HoReCa, and E-commerce, which is critical for scaling the company's institutional and food service business. This strategic hire is expected to strengthen the company's go-to-market strategies and drive profitable growth in the B2B segment.
Key Highlights
Appointment of Tushar Srivastava as Senior Director - TFS effective March 09, 2026
Candidate brings over 28 years of experience from top-tier firms like P&G, Kellogg's, and PepsiCo
Expertise includes leadership roles at Jubilant FoodWorks and Walmart, focusing on HoReCa and retail channels
Educational background includes a PG in Marketing and an Executive General Management Programme from IIM Bangalore
👀 What to Watch
Investors should view this as a positive step towards strengthening the institutional business segment. Monitor the company's performance in the Food Service (TFS) division over the coming quarters to gauge the impact of this leadership addition.
SBI Cards Declares Interim Dividend of Rs 2.50 Per Share for FY 2025-26
The Board of Directors of SBI Cards and Payment Services Limited has declared an interim dividend of Rs. 2.50 per equity share for the financial year 2025-26. This payout represents 25% of the face value of Rs. 10 per share. The company has established March 11, 2026, as the record date to identify eligible shareholders. Following new SEBI regulations, the dividend will be distributed solely through electronic modes, with no physical warrants or cheques being issued.
Key Highlights
Interim dividend declared at Rs. 2.50 per equity share (25% of face value).
Record date for dividend entitlement is fixed as Wednesday, March 11, 2026.
Dividend payment will be strictly electronic as per SEBI Fifth Amendment Regulations, 2025.
Shareholders must update bank details with Depository Participants to receive funds.
The decision was finalized in the Board meeting held on March 05, 2026.
👀 What to Watch
Investors should ensure their bank account, PAN, and KYC details are updated with their DP by the record date to ensure seamless credit. The stock will likely trade ex-dividend shortly before March 11, 2026.
Bikaji Foods Completes 100% Acquisition of Petunt Food Processors for ₹8 Crore
Bikaji Foods International has finalized the acquisition of the remaining 48.78% stake in Petunt Food Processors Private Limited (PFPPL), making it a wholly-owned subsidiary. The transaction was completed for a cash consideration of ₹8 crore, aimed at consolidating control over operations in the South Indian territory. PFPPL has demonstrated steady growth, with turnover rising from ₹36.36 crore in FY23 to ₹52.07 crore in FY25. This move allows Bikaji to fully integrate PFPPL's manufacturing and distribution capabilities into its core FMCG business.
Key Highlights
Acquired remaining 48.78% stake (35,98,998 shares) for a cash consideration of ₹8 crore
PFPPL turnover increased to ₹52.07 crore in FY25, up from ₹42.70 crore in FY24
Target entity is now a 100% Wholly-Owned Subsidiary of Bikaji Foods
Strategic focus on strengthening operational control and footprint in the South Indian market
Acquisition completed on March 06, 2026, following the board approval in November 2025
👀 What to Watch
Investors should look favorably on this consolidation as it simplifies the corporate structure and gives Bikaji full control over a growing regional asset. The acquisition cost seems attractive relative to the target's ₹52 crore annual turnover.
India Ratings Assigns 'IND AAA/Stable' to SBI's INR 75 Billion Tier II Bonds; Affirms Ratings
India Ratings has assigned a top-tier 'IND AAA/Stable' rating to SBI's new INR 75 billion Basel III Tier II bonds while affirming existing ratings for its infrastructure and AT1 bonds. The bank continues to dominate the Indian banking sector with a 22.5% deposit market share and 19.4% share in net advances as of FY25. Asset quality remains a key strength, with GNPA improving to 1.57% and NNPA at 0.39% in 9MFY26. Management expects to maintain a Return on Assets (RoA) of around 1.1% and credit growth between 12-14% for FY26.
Key Highlights
Assigned 'IND AAA/Stable' to new INR 75 billion Tier II bonds and affirmed 'IND AAA' for INR 400 billion infra bonds.
Gross NPA improved to 1.57% and Net NPA to 0.39% as of 9MFY26, surpassing most public sector peers.
Maintains a dominant 22.5% market share in deposits and 19.4% in advances with a massive network of 23,125 branches.
Capital adequacy remains stable with a CET1 ratio of 10.99% and a target Return on Equity (RoE) exceeding 15%.
Liquidity remains superior with a Liquidity Coverage Ratio (LCR) of 137.61% as of December 2025.
👀 What to Watch
The affirmation of the highest credit ratings underscores SBI's systemic importance and robust balance sheet. Investors can remain confident in the bank's stability and its ability to maintain profitability despite minor NIM pressures.
SBI Cards Declares Interim Dividend of Rs 2.50 Per Share; Sets Record Date for March 11, 2026
SBI Cards and Payment Services has declared an interim dividend of Rs 2.50 per equity share for the financial year 2025-26, which is 25% of the face value. The company has established March 11, 2026, as the record date to identify eligible shareholders for this payout. The dividend is scheduled to be credited or dispatched to shareholders on or before April 3, 2026. Additionally, the board has extended the term of Mr. Ved Prakash, the Head of Internal Audit, for a period of four months to ensure management continuity.
Key Highlights
Interim dividend of Rs 2.50 per equity share (25% of face value) declared for FY 2025-26
Record date for dividend entitlement is fixed as Wednesday, March 11, 2026
Dividend payment to be completed on or before April 3, 2026
Term extension for Mr. Ved Prakash as EVP & Head - Internal Audit until June 30, 2026
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the record date of March 11, 2026. The dividend yield and management stability in the audit department are positive indicators for long-term holders.
SBI Cards Declares Rs 2.50 Interim Dividend; Extends Head of Internal Audit's Term
SBI Cards and Payment Services has declared an interim dividend of Rs. 2.50 per equity share (25% of face value) for the financial year 2025-26. The record date for determining shareholder eligibility is set for March 11, 2026, with the payout expected by April 3, 2026. Additionally, the company has extended the tenure of Mr. Ved Prakash, Executive Vice President & Head of Internal Audit, for a period of four months until June 30, 2026. This extension aims to ensure continuity in the company's internal audit and governance functions.
Key Highlights
Interim dividend declared at Rs. 2.50 per share, representing 25% of the Rs. 10 face value
Record date for dividend entitlement is fixed as Wednesday, March 11, 2026
Dividend disbursement to be completed on or before April 3, 2026
Term extension for Mr. Ved Prakash as EVP & Head-Internal Audit from March 1 to June 30, 2026
Mr. Ved Prakash carries over 31 years of banking experience, primarily from State Bank of India
👀 What to Watch
Investors seeking the dividend should ensure they hold the shares before the record date of March 11, 2026. The management extension indicates a focus on stability in internal oversight during the current transition period.
SBI Cards Declares Rs 2.50 Interim Dividend; Extends Internal Audit Head's Term
SBI Cards and Payment Services has declared an interim dividend of Rs. 2.50 per equity share for the financial year 2025-26, representing a 25% payout on the face value of Rs. 10. The company has fixed March 11, 2026, as the record date for determining shareholder eligibility, with the payout scheduled to be completed by April 3, 2026. Additionally, the board has approved a four-month extension for Mr. Ved Prakash as Executive Vice President and Head of Internal Audit. This extension ensures management continuity in a critical oversight role through June 30, 2026.
Key Highlights
Interim dividend of Rs. 2.50 per equity share (25% of face value) declared for FY 2025-26
Record date for dividend entitlement is fixed as March 11, 2026
Dividend payment to be credited or dispatched on or before April 3, 2026
Term extension for Mr. Ved Prakash, Head of Internal Audit, for 4 months until June 30, 2026
Mr. Ved Prakash brings over 31 years of experience from State Bank of India
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the record date of March 11, 2026. The dividend yield and management continuity are positive indicators for long-term stability.
SBI Cards Declares Interim Dividend of Rs 2.50 per Share for FY 2025-26
SBI Cards and Payment Services has declared an interim dividend of Rs. 2.50 per equity share, which is 25% of the face value of Rs. 10. The company has fixed March 11, 2026, as the record date to determine eligible shareholders for this payout. The dividend is scheduled to be credited or dispatched to shareholders on or before April 3, 2026. Additionally, the board approved a four-month extension for Mr. Ved Prakash as the Head of Internal Audit until June 30, 2026.
Key Highlights
Interim dividend of Rs. 2.50 per equity share (25% of face value) declared for FY 2025-26
Record date for dividend entitlement is set for March 11, 2026
Dividend payment to be completed by April 3, 2026
Extension of term for Mr. Ved Prakash, Head of Internal Audit, for 4 months until June 30, 2026
👀 What to Watch
Investors interested in the dividend must hold the shares before the record date of March 11, 2026. The stock remains a key play in the Indian credit card penetration story.
NBIFIN Shareholders Approve Object Clause Alteration and New Director Appointments
N. B. I. Industrial Finance Company Limited (NBIFIN) has announced the successful passage of three key resolutions via postal ballot with overwhelming shareholder support. Approximately 99.97% of votes were cast in favor of altering the company's Object Clause, providing potential for business diversification. Additionally, shareholders approved the appointments of Shri Mohan Bangur and Shri Prashant Bangur as Non-Executive Non-Independent Directors. The voting process, which concluded on March 4, 2026, reflects strong investor confidence in the current management and strategic direction.
Key Highlights
Special Resolution to alter the Object Clause passed with 2,12,69,019 votes (99.97%) in favor
Appointment of Shri Mohan Bangur as Non-Executive Non-Independent Director approved with 99.97% majority
Appointment of Shri Prashant Bangur as Non-Executive Non-Independent Director approved with 99.97% majority
Only 715 votes were cast against each of the three resolutions, showing high consensus
The voting period was conducted from February 3, 2026, to March 4, 2026
👀 What to Watch
Investors should view the high approval rates as a sign of management stability and monitor future announcements regarding how the altered Object Clause will be utilized for business expansion.
SBI Life Tax Demand Reduced by ₹4,846 Crore to ₹470.88 Crore Following Rectification
SBI Life Insurance has received a significant rectification order from the Income Tax Department for FY 2021-22, correcting a previously erroneous demand. The total tax and interest demand has been slashed from ₹5,317.18 crore to ₹470.88 crore after the company filed a rectification application highlighting calculation errors. This reduction of over 90% in the potential liability provides substantial financial relief. The company is continuing its appeal against the remaining demand before the Commissioner (Appeals).
Key Highlights
Total tax demand for FY 2021-22 reduced from ₹5,317.18 crore to ₹470.88 crore
Tax component specifically decreased from ₹4,286.63 crore to ₹315.84 crore
Interest component slashed from ₹1,030.55 crore to ₹155.04 crore
Rectification order issued under Section 154 of the Income Tax Act, 1961
Company maintains its appeal against the revised demand at the Commissioner Appeals level
👀 What to Watch
This massive reduction in tax demand removes a significant financial overhang and is a major positive for the stock. Investors should continue to monitor the final resolution of the remaining ₹470.88 crore appeal.
A B Infrabuild Secures ₹62.94 Crore NHAI Project in Odisha
A B Infrabuild Limited has received a Letter of Acceptance from the National Highways Authority of India (NHAI) for a road infrastructure project in Odisha. The contract involves the construction of three Vehicular Underpasses (VUPs) and associated service roads on NH-16. The total value of the order is approximately ₹62.94 Crore, to be executed within an 18-month timeframe. This domestic project on EPC mode strengthens the company's order book and revenue visibility.
Key Highlights
Contract awarded by National Highways Authority of India (NHAI) for work on NH-16 in Odisha.
Total order value stands at ₹62.94 Crore (Rs. 62,94,04,813.35).
Project scope includes construction of 3 Vehicular Underpasses (VUPs) and service roads.
The project is to be executed on EPC mode within a period of 18 months.
👀 What to Watch
Investors should view this as a positive development for the company's order book and monitor execution progress. The successful completion of this NHAI project could lead to larger contract opportunities in the future.
Biocon to Invest Rs 315.34 Crore in Subsidiaries Biocon Biosphere and Biocon Pharma
Biocon Limited has announced a total investment of Rs 315.34 crore into its wholly owned subsidiaries, Biocon Biosphere Limited (BBSL) and Biocon Pharma Limited (BPL). The investment is structured through the acquisition of Optionally Convertible Redeemable Non-Cumulative Preference Shares (OCRPS). For BBSL, the investment of Rs 115.34 crore involves a cash infusion of Rs 20 crore and the conversion of existing loans worth Rs 95.34 crore. For BPL, the company is injecting Rs 200 crore in cash to support working capital and general corporate requirements.
Key Highlights
Total investment of Rs 315.34 crore across two wholly owned subsidiaries via OCRPS at Rs 10 per share.
Biocon Pharma Limited (BPL) receives Rs 200 crore in cash for working capital and corporate needs.
Biocon Biosphere Limited (BBSL) receives Rs 115.34 crore, including conversion of Rs 95.34 crore debt and interest into equity-like instruments.
BPL showed steady growth with FY25 turnover reaching Rs 9,825 million compared to Rs 8,816 million in FY24.
BBSL is scaling up operations with turnover rising from Rs 6 million in FY24 to Rs 130 million in FY25.
👀 What to Watch
This is a routine internal capital allocation to support the growth and working capital needs of subsidiaries. Investors should monitor if this funding helps BPL and BBSL achieve better profitability and scale in the generic formulations and API segments.
Fitch Upgrades SBI's Viability Rating to 'bb+'; Affirms Long-Term IDR at 'BBB-'
Fitch Ratings has upgraded State Bank of India's (SBI) Viability Rating (VR) to 'bb+' from 'bb', citing sustained improvements in asset quality, capitalization, and profitability. The bank's Long-Term Issuer Default Rating (IDR) was affirmed at 'BBB-' with a Stable outlook, reflecting its systemic importance and strong government support. SBI's Common Equity Tier 1 (CET1) ratio saw a significant jump to 12.6% in 9MFY26 from 10.8% in FY25. Asset quality remains healthy with an impaired-loan ratio of 1.6% and a robust liquidity coverage ratio of 138%.
Key Highlights
Viability Rating (VR) upgraded to 'bb+' from 'bb' reflecting improved intrinsic financial strength.
CET1 ratio increased to 12.6% in 9MFY26 from 10.8% in FY25, bolstered by a 2025 equity raise.
Impaired-loan ratio improved to 1.6% as of 9MFY26, with Fitch forecasting it to stay at this level through FY27.
Customer deposits comprise 90% of total funding, highlighting a very stable liquidity profile.
Operating profit/risk-weighted asset ratio expected to remain steady at approximately 2.5%.
👀 What to Watch
The upgrade in the viability rating underscores SBI's strengthening balance sheet and superior risk oversight compared to state-owned peers. Investors should view this as a positive reinforcement of the bank's dominant market position and improved capital cushions.
Panacea Biotec Receives ₹45.71 Crore Income Tax Demand for AY 2015-16
Panacea Biotec has received a demand order of ₹45.71 crore from the Income Tax Department for the Assessment Year 2015-16. The demand stems from the disallowance of certain expenditures under Section 37 of the IT Act, which the authorities allege violated Medical Council of India (MCI) regulations. The company contends that the demand is misplaced as it has sufficient brought-forward losses to offset any taxable income. Management is currently pursuing legal remedies, including filing a rectification application and an appeal before the relevant authorities.
Key Highlights
Total tax demand of ₹45.71 crore including interest for Assessment Year 2015-16.
Demand issued by the Deputy Commissioner of Income Tax, Central Circle 29, Delhi.
Disallowances based on alleged violations of Medical Council of India (MCI) Regulations.
Company claims no actual tax liability due to availability of brought-forward losses.
Legal recourse initiated via rectification application and appellate authority appeal.
👀 What to Watch
Investors should monitor the progress of the appeal and rectification process, as any final unfavorable ruling could impact the company's financial position despite the current claim of tax losses.
SBI Life Seeks Approval for ₹70,900 Cr+ Related Party Transactions for FY 2026-27
SBI Life Insurance has issued a postal ballot notice seeking shareholder approval for material related party transactions (RPTs) for the upcoming financial year 2026-27. The company proposes transactions with State Bank of India (SBI) totaling ₹40,900 crore and with SBI DFHI Limited totaling ₹30,000 crore. These transactions primarily involve investment purchases and sales, premium income, and commission expenses conducted at arm's length. Shareholders can cast their votes via e-voting from March 1 to March 30, 2026.
Key Highlights
Proposed RPT with State Bank of India (SBI) capped at ₹40,900 crore for FY 2026-27.
Proposed RPT with SBI DFHI Limited capped at ₹30,000 crore for investment-related activities.
SBI transactions include ₹15,000 crore for investment purchases and ₹4,400 crore for commission expenses.
Premium income from SBI-related business is estimated at ₹6,000 crore for the fiscal year.
E-voting period is scheduled from March 1, 2026, to March 30, 2026, with results by April 2, 2026.
👀 What to Watch
This is a routine regulatory requirement for listed companies to approve transactions with parent and group entities. Investors should note the scale of synergy with SBI, which remains a key driver for the company's distribution and investment strategy.
SBI Cards Board to Consider Interim Dividend on March 5; Record Date Set for March 11
SBI Cards and Payment Services Limited has scheduled a Board meeting on March 5, 2026, to consider and potentially declare an interim dividend for the financial year 2025-26. The company has proactively fixed March 11, 2026, as the record date to determine shareholder eligibility for the payout. In compliance with insider trading regulations, the trading window for the company's securities is closed from February 27 to March 7, 2026. This announcement indicates the company's intent to share profits with its investors.
Key Highlights
Board meeting scheduled for March 5, 2026, to consider interim dividend declaration.
Record date for dividend eligibility fixed as March 11, 2026.
Trading window for designated persons closed from February 27 to March 7, 2026.
Dividend consideration pertains to the financial year 2025-26.
👀 What to Watch
Investors should monitor the Board meeting outcome on March 5 for the specific dividend amount. To be eligible for the dividend, ensure shares are held in the demat account before the ex-dividend date.
SBI Cards Board Meeting on March 5 to Consider Interim Dividend; Record Date March 11
SBI Cards and Payment Services Limited has scheduled a Board Meeting on March 5, 2026, to consider the declaration of an interim dividend for the financial year 2025-26. The company has established March 11, 2026, as the record date for determining shareholder eligibility, should the dividend be approved. In line with SEBI insider trading regulations, the trading window for the company's securities is closed from February 27 to March 7, 2026. This announcement suggests a potential cash payout to shareholders in the near term.
Key Highlights
Board meeting scheduled for March 5, 2026, to discuss interim dividend for FY 2025-26.
Record date for dividend eligibility fixed as March 11, 2026, subject to board approval.
Trading window for designated persons closed from February 27, 2026, to March 7, 2026.
The dividend, if declared, will be paid to shareholders appearing in records as of the record date.
👀 What to Watch
Investors should monitor the March 5 board meeting outcome for the specific dividend amount per share. To be eligible for the payout, ensure shares are held in your demat account before the March 11 record date.
Concord Biotech Q3 Revenue Up 14% YoY to ₹278 Cr; PAT Dips 8.5% on Exceptional Costs
Concord Biotech reported a 13.9% YoY increase in revenue from operations to ₹27,813 lakhs for Q3 FY26. However, Net Profit (PAT) declined by 8.5% YoY to ₹6,778 lakhs, primarily impacted by a one-time exceptional charge of ₹327.54 lakhs related to new labour code regulations. On a sequential basis, the company showed recovery with revenue and PAT growing 12.6% and 7.8% respectively compared to Q2 FY26. The board also strengthened its leadership by appointing Mr. Paritosh Trivedi as the new Company Secretary and Compliance Officer.
Key Highlights
Revenue from operations grew 13.9% YoY to ₹27,813.39 lakhs in Q3 FY26 compared to ₹24,422.02 lakhs in Q3 FY25.
Net Profit (PAT) for the quarter stood at ₹6,778.27 lakhs, a decline from ₹7,408.88 lakhs in the corresponding quarter last year.
Recognized an exceptional item of ₹327.54 lakhs due to the statutory impact of new labour codes on employee benefit obligations.
9-month PAT for FY26 shows a significant decline to ₹17,324.46 lakhs from ₹23,102.69 lakhs in the same period last year.
Appointed Mr. Paritosh Trivedi as Company Secretary and Compliance Officer effective February 11, 2026.
👀 What to Watch
Investors should monitor the margin pressure as PAT has declined despite healthy revenue growth. The significant year-to-date profit lag compared to the previous fiscal suggests a cautious outlook until bottom-line growth stabilizes.
